A two-step approach with sequencing of 20,000 genes improves prediction of who benefits from immune checkpoint inhibitors NEW YORK, NY (July 8, 2022) — Immunotherapies, such as immune checkpoint inhibitors, have transformed the treatment of advanced stage cancers. Unlike chemotherapies that kill cancer cells, these drugs help the body’s immune system to find and destroy […]
Genome-wide approaches to engineer more effective anti-cancer immunotherapy NEW YORK, NY (March 16, 2022) – The first FDA-approved gene therapies are living drugs: immune cells taken from cancer patients engineered to target tumor cells. However, for many patients, these advanced therapies do not result in a long-lasting remission. Now, scientists at the New York Genome […]
